USA: +1 347 690-0211 | UK: +44 2032 894158 | JAPAN: +81 50 5806 9039 | Translate : 

report img

Blood Plasma Fractionation Market By Product (Albumin, Immunoglobulin, Coagulation Factors, Protease Inhibitors, Others), By Application (Immunology & Neurology, Hematology, Critical Care, Pulmonology, & Others), By End-User (Hospitals & Clinics, Research Laboratories, & Academic Institutes), And By Regions - Global & Regional Industry Perspective, Comprehensive Analysis, and Forecast 2021 - 2026

Covid-19

Blood Plasma Fractionation Market

The pandemic continues to cause unprecedented disruption across industries worldwide.Get detailed insights regarding the impact of COVID-19 on the market. Request Sample

Industry Insights

[171+ Pages Report] We at Facts & Factors have recently published a report titled “Blood Plasma Fractionation Market” that encompasses the spectacle of the market in an analytical and comprehensive manner. The global blood plasma fractionation market is estimated to value USD 37.43 Billion in the year 2026 from an initial value of USD 27.6 Billion in the year 2020, with growth at a CAGR value of 5.9% during 2021-2026.

logoGlobal Blood Plasma Fractionation Market: Overview

Blood plasma fractionation is the general process of separating various components of blood plasma from the blood, which in turn is a by-product of the process that is known as blood fractionation. Plasma-derived immunoglobulins are expected to derive a newer format of narrative toward the healthcare sector across a wide range of autoimmune inflammatory diseases.

logoGlobal Blood Plasma Fractionation Market: Growth Factors

The pivotal factors that are responsible for the significant growth of the global blood plasma fractionation market are the rising usage of immunoglobulins in various therapeutics use cases coupled with rising plasma collection to name a few. Additionally, the increasing geriatric population coupled with the increasing prevalence of respiratory diseases is expected to increase the footprint of the global blood plasma fractionation market during the forecast period. Moreover, increasing amount of disorders relating to alpha-1-antitrypsin deficiency (AATD) coupled with rising applications of intravenous immunoglobulin (IVIg) is expected to open new revenue opportunities for the global blood plasma fractionation market during the forecast duration.

Additionally, the market is expected to be driven by disorders relating to blood plasma, prophylaxis of hemophilia which in turn will give a boost to the global blood plasma fractionation market during the forecast period. Rising adoption and higher utilization of immunoglobulins being used for treatment of Alzheimer’s and other immune autoimmune disorders will fuel the growth of the global blood plasma fractionation market during the forecast period. However, higher cost of plasma-derived products and rising number of recombinant alternatives will hamper the growth of the global blood plasma fractionation market during the forecast duration.

logoGlobal Blood Plasma Fractionation Market: Segmentation

The global blood plasma fractionation market is segmented into product, application, end-user, and regions.

On the basis of product, the global blood plasma fractionation market is divided into albumin, immunoglobulin, coagulation factors, protease inhibitors, and others. The segment pertaining to protease inhibitors are expected to witness the largest market share during the advent of the forecast owing to higher efficacy coupled with a duality usage of the latter in the form of antiviral agents. The global blood plasma fractionation market is categorized into immunology & neurology, hematology, critical care, pulmonology, and others on the basis of application. The immunology and neurology segment is expected to witness the largest market share during the advent of the forecast owing to extensive uses of plasma proteins for coagulation and immunoglobulin in the sector of neurology and research and development procedures to name a few. Based on end-user, the global blood plasma fractionation market is fragmented into hospitals & clinics, research laboratories, and academic institutes. The segment pertaining to hospitals and clinics is expected to witness the largest market share during the advent of the forecast owing to higher requirement of plasma from advanced clinic settings for treatment of complex disorders coupled with increasing number of in-patient population.

logoGlobal Blood Plasma Fractionation Market: Regional Analysis

North America is expected to witness the largest market share during the advent of the forecast owing to the rising number of research and development applications in the region coupled with well-developed and maintained healthcare infrastructure to name a few. Additionally, favorable government regulations coupled with rising number of approvals aimed at blood plasma fractionation devices are expected to increase the footprint of the latter market during the forecast. Moreover, rising prevalence of rare diseases in the region coupled with increasing investments in fractionation systems will open new revenue opportunities for the blood plasma fractionation market during the forecast period. The rising geriatric population coupled with AATD related disorders will boost the blood plasma fractionation market during the forecast period.

logoGlobal Blood Plasma Fractionation Market: Competitive Players

The global key market participants for the global blood plasma fractionation market are CSL, Grifols, Shire, Octapharma, Kedrion, BPL, Baxter International, Inc., Bio Product Laboratory, Biotest AG, LFB, Sanquin Blood Supply Foundation, and Takeda Pharmaceutical Company Limited, among others.

logoGlobal Blood Plasma Fractionation Market: By Product Segment Analysis

  • Albumin
  • Immunoglobulin
    • Intravenous Immunoglobulin
    • Subcutaneous Immunoglobulin
  • Coagulation Factors
    • Factor IX
    • Factor VIII
    • Fibrinogen Concentrates
  • Protease Inhibitors
  • Others

logoGlobal Blood Plasma Fractionation Market: By Application Segment Analysis

  • Immunology & Neurology
  • Hematology
  • Critical Care
  • Pulmonology
  • Others

logoGlobal Blood Plasma Fractionation Market: By End-User Segment Analysis

  • Hospitals & Clinics
  • Research Laboratories
  • Academic Institutes
key report pointers

Covid-19

Blood Plasma Fractionation Market

The pandemic continues to cause unprecedented disruption across industries worldwide.Get detailed insights regarding the impact of COVID-19 on the market. Request Sample

Table of Content

  1. Chapter 1 Executive Summary
    1. 1.1. Introduction of Blood Plasma Fractionation
    2. 1.2. Global Blood Plasma Fractionation Market, 2019 & 2026 (USD Billion)
    3. 1.3. Global Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
    4. 1.4. Global Blood Plasma Fractionation Market Absolute Revenue Opportunity, 2016 – 2026 (USD Billion)
    5. 1.5. Global Blood Plasma Fractionation Market Incremental Revenue Opportunity, 2020 – 2026 (USD Billion)
  2. Chapter 2 Blood Plasma Fractionation Market – Product Analysis
    1. 2.1. Global Blood Plasma Fractionation Market – Product Overview
    2. 2.2. Global Blood Plasma Fractionation Market Share, by Product, 2019 & 2026 (USD Billion)
    3. 2.3. Albumin
      1. 2.3.1. Global Albumin Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
    4. 2.4. Immunoglobulin
      1. 2.4.1. Global Immunoglobulin Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
    5. 2.5. Coagulation Factors
      1. 2.5.1. Global Coagulation Factors Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
    6. 2.6. Protease Inhibitors
      1. 2.6.1. Global Protease Inhibitors Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
    7. 2.7. Others
      1. 2.7.1. Global Others Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
  3. Chapter 3 Blood Plasma Fractionation Market – Application Analysis
    1. 3.1. Global Blood Plasma Fractionation Market – Application Overview
    2. 3.2. Global Blood Plasma Fractionation Market Share, by Application, 2019 & 2026 (USD Billion)
    3. 3.3. Immunology & Neurology
      1. 3.3.1. Global Immunology & Neurology Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
    4. 3.4. Hematology
      1. 3.4.1. Global Hematology Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
    5. 3.5. Critical Care
      1. 3.5.1. Global Critical Care Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
    6. 3.6. Pulmonology
      1. 3.6.1. Global Pulmonology Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
    7. 3.7. Others
      1. 3.7.1. Global Others Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
  4. Chapter 4 Blood Plasma Fractionation Market – End-User Analysis
    1. 4.1. Global Blood Plasma Fractionation Market – End-User Overview
    2. 4.2. Global Blood Plasma Fractionation Market Share, by End-User, 2019 & 2026 (USD Billion)
    3. 4.3. Hospitals & Clinics
      1. 4.3.1. Global Hospitals & Clinics Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
    4. 4.4. Research Laboratories
      1. 4.4.1. Global Research Laboratories Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
    5. 4.5. Academic Institutes
      1. 4.5.1. Global Academic Institutes Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
  5. Chapter 5 Blood Plasma Fractionation Market – Regional Analysis
    1. 5.1. Global Blood Plasma Fractionation Market Regional Overview
    2. 5.2. Global Blood Plasma Fractionation Market Share, by Region, 2019 & 2026 (USD Billion)
    3. 5.3. North America
      1. 5.3.1. North America Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
        1. 5.3.1.1. North America Blood Plasma Fractionation Market, by Country, 2016 - 2026 (USD Billion)
      2. 5.3.2. North America Blood Plasma Fractionation Market, by Product, 2016 – 2026
        1. 5.3.2.1. North America Blood Plasma Fractionation Market, by Product, 2016 – 2026 (USD Billion)
      3. 5.3.3. North America Blood Plasma Fractionation Market, by Application, 2016 – 2026
        1. 5.3.3.1. North America Blood Plasma Fractionation Market, by Application, 2016 – 2026 (USD Billion)
      4. 5.3.4. North America Blood Plasma Fractionation Market, by End-User, 2016 – 2026
        1. 5.3.4.1. North America Blood Plasma Fractionation Market, by End-User, 2016 – 2026 (USD Billion)
      5. 5.3.5. U.S.
        1. 5.3.5.1. U.S. Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
      6. 5.3.6. Canada
        1. 5.3.6.1. Canada Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
    4. 5.4. Europe
      1. 5.4.1. Europe Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
        1. 5.4.1.1. Europe Blood Plasma Fractionation Market, by Country, 2016 - 2026 (USD Billion)
      2. 5.4.2. Europe Blood Plasma Fractionation Market, by Product, 2016 – 2026
        1. 5.4.2.1. Europe Blood Plasma Fractionation Market, by Product, 2016 – 2026 (USD Billion)
      3. 5.4.3. Europe Blood Plasma Fractionation Market, by Application, 2016 – 2026
        1. 5.4.3.1. Europe Blood Plasma Fractionation Market, by Application, 2016 – 2026 (USD Billion)
      4. 5.4.4. Europe Blood Plasma Fractionation Market, by End-User, 2016 – 2026
        1. 5.4.4.1. Europe Blood Plasma Fractionation Market, by End-User, 2016 – 2026 (USD Billion)
      5. 5.4.5. Germany
        1. 5.4.5.1. Germany Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
      6. 5.4.6. France
        1. 5.4.6.1. France Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
      7. 5.4.7. U.K.
        1. 5.4.7.1. U.K. Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
      8. 5.4.8. Italy
        1. 5.4.8.1. Italy Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
      9. 5.4.9. Spain
        1. 5.4.9.1. Spain Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
      10. 5.4.10. Rest of Europe
        1. 5.4.10.1. Rest of Europe Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
    5. 5.5. Asia Pacific
      1. 5.5.1. Asia Pacific Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
        1. 5.5.1.1. Asia Pacific Blood Plasma Fractionation Market, by Country, 2016 - 2026 (USD Billion)
      2. 5.5.2. Asia Pacific Blood Plasma Fractionation Market, by Product, 2016 – 2026
        1. 5.5.2.1. Asia Pacific Blood Plasma Fractionation Market, by Product, 2016 – 2026 (USD Billion)
      3. 5.5.3. Asia Pacific Blood Plasma Fractionation Market, by Application, 2016 – 2026
        1. 5.5.3.1. Asia Pacific Blood Plasma Fractionation Market, by Application, 2016 – 2026 (USD Billion)
      4. 5.5.4. Asia Pacific Blood Plasma Fractionation Market, by End-User, 2016 – 2026
        1. 5.5.4.1. Asia Pacific Blood Plasma Fractionation Market, by End-User, 2016 – 2026 (USD Billion)
      5. 5.5.5. China
        1. 5.5.5.1. China Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
      6. 5.5.6. Japan
        1. 5.5.6.1. Japan Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
      7. 5.5.7. India
        1. 5.5.7.1. India Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
      8. 5.5.8. South Korea
        1. 5.5.8.1. South Korea Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
      9. 5.5.9. South-East Asia
        1. 5.5.9.1. South-East Asia Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
      10. 5.5.10. Rest of Asia Pacific
        1. 5.5.10.1. Rest of Asia Pacific Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
    6. 5.6. Latin America
      1. 5.6.1. Latin America Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
        1. 5.6.1.1. Latin America Blood Plasma Fractionation Market, by Country, 2016 - 2026 (USD Billion)
      2. 5.6.2. Latin America Blood Plasma Fractionation Market, by Product, 2016 – 2026
        1. 5.6.2.1. Latin America Blood Plasma Fractionation Market, by Product, 2016 – 2026 (USD Billion)
      3. 5.6.3. Latin America Blood Plasma Fractionation Market, by Application, 2016 – 2026
        1. 5.6.3.1. Latin America Blood Plasma Fractionation Market, by Application, 2016 – 2026 (USD Billion)
      4. 5.6.4. Latin America Blood Plasma Fractionation Market, by End-User, 2016 – 2026
        1. 5.6.4.1. Latin America Blood Plasma Fractionation Market, by End-User, 2016 – 2026 (USD Billion)
      5. 5.6.5. Brazil
        1. 5.6.5.1. Brazil Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
      6. 5.6.6. Mexico
        1. 5.6.6.1. Mexico Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
      7. 5.6.7. Rest of Latin America
        1. 5.6.7.1. Rest of Latin America Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
    7. 5.7. The Middle-East and Africa
      1. 5.7.1. The Middle-East and Africa Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
        1. 5.7.1.1. The Middle-East and Africa Blood Plasma Fractionation Market, by Country, 2016 - 2026 (USD Billion)
      2. 5.7.2. The Middle-East and Africa Blood Plasma Fractionation Market, by Product, 2016 – 2026
        1. 5.7.2.1. The Middle-East and Africa Blood Plasma Fractionation Market, by Product, 2016 – 2026 (USD Billion)
      3. 5.7.3. The Middle-East and Africa Blood Plasma Fractionation Market, by Application, 2016 – 2026
        1. 5.7.3.1. The Middle-East and Africa Blood Plasma Fractionation Market, by Application, 2016 – 2026 (USD Billion)
      4. 5.7.4. The Middle-East and Africa Blood Plasma Fractionation Market, by End-User, 2016 – 2026
        1. 5.7.4.1. The Middle-East and Africa Blood Plasma Fractionation Market, by End-User, 2016 – 2026 (USD Billion)
      5. 5.7.5. GCC Countries
        1. 5.7.5.1. GCC Countries Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
      6. 5.7.6. South Africa
        1. 5.7.6.1. South Africa Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
      7. 5.7.7. Rest of Middle-East Africa
        1. 5.7.7.1. Rest of Middle-East Africa Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
  6. Chapter 6 Blood Plasma Fractionation Market – Competitive Landscape
    1. 6.1. Competitor Market Share – Revenue
    2. 6.2. Market Concentration Rate Analysis, Top 3 and Top 5 Players
    3. 6.3. Strategic Developments
      1. 6.3.1. Acquisitions and Mergers
      2. 6.3.2. New Products
      3. 6.3.3. Research & Development Activities
  7. Chapter 7 Company Profiles
    1. 7.1. CSL
      1. 7.1.1. Company Overview
      2. 7.1.2. Product/Service Portfolio
      3. 7.1.3. CSL Sales, Revenue, and Gross Margin
      4. 7.1.4. CSL Revenue and Growth Rate
      5. 7.1.5. CSL Market Share
      6. 7.1.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    2. 7.2. Grifols
      1. 7.2.1. Company Overview
      2. 7.2.2. Product/Service Portfolio
      3. 7.2.3. Grifols Sales, Revenue, and Gross Margin
      4. 7.2.4. Grifols Revenue and Growth Rate
      5. 7.2.5. Grifols Market Share
      6. 7.2.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    3. 7.3. Shire
      1. 7.3.1. Company Overview
      2. 7.3.2. Product/Service Portfolio
      3. 7.3.3. Shire Sales, Revenue, and Gross Margin
      4. 7.3.4. Shire Revenue and Growth Rate
      5. 7.3.5. Shire Market Share
      6. 7.3.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    4. 7.4. Octapharma
      1. 7.4.1. Company Overview
      2. 7.4.2. Product/Service Portfolio
      3. 7.4.3. Octapharma Sales, Revenue, and Gross Margin
      4. 7.4.4. Octapharma Revenue and Growth Rate
      5. 7.4.5. Octapharma Market Share
      6. 7.4.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    5. 7.5. Kedrion
      1. 7.5.1. Company Overview
      2. 7.5.2. Product/Service Portfolio
      3. 7.5.3. Kedrion Sales, Revenue, and Gross Margin
      4. 7.5.4. Kedrion Revenue and Growth Rate
      5. 7.5.5. Kedrion Market Share
      6. 7.5.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    6. 7.6. BPL
      1. 7.6.1. Company Overview
      2. 7.6.2. Product/Service Portfolio
      3. 7.6.3. BPL Sales, Revenue, and Gross Margin
      4. 7.6.4. BPL Revenue and Growth Rate
      5. 7.6.5. BPL Market Share
      6. 7.6.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    7. 7.7. Baxter International Inc
      1. 7.7.1. Company Overview
      2. 7.7.2. Product/Service Portfolio
      3. 7.7.3. Baxter International Inc Sales, Revenue, and Gross Margin
      4. 7.7.4. Baxter International Inc Revenue and Growth Rate
      5. 7.7.5. Baxter International Inc Market Share
      6. 7.7.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    8. 7.8. Bio Product Laboratory
      1. 7.8.1. Company Overview
      2. 7.8.2. Product/Service Portfolio
      3. 7.8.3. Bio Product Laboratory Sales, Revenue, and Gross Margin
      4. 7.8.4. Bio Product Laboratory Revenue and Growth Rate
      5. 7.8.5. Bio Product Laboratory Market Share
      6. 7.8.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    9. 7.9. Biotest AG
      1. 7.9.1. Company Overview
      2. 7.9.2. Product/Service Portfolio
      3. 7.9.3. Biotest AG Sales, Revenue, and Gross Margin
      4. 7.9.4. Biotest AG Revenue and Growth Rate
      5. 7.9.5. Biotest AG Market Share
      6. 7.9.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    10. 7.10. LFB
      1. 7.10.1. Company Overview
      2. 7.10.2. Product/Service Portfolio
      3. 7.10.3. LFB Sales, Revenue, and Gross Margin
      4. 7.10.4. LFB Revenue and Growth Rate
      5. 7.10.5. LFB Market Share
      6. 7.10.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    11. 7.11. Sanquin Blood Supply Foundation
      1. 7.11.1. Company Overview
      2. 7.11.2. Product/Service Portfolio
      3. 7.11.3. Sanquin Blood Supply Foundation Sales, Revenue, and Gross Margin
      4. 7.11.4. Sanquin Blood Supply Foundation Revenue and Growth Rate
      5. 7.11.5. Sanquin Blood Supply Foundation Market Share
      6. 7.11.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    12. 7.12. Takeda Pharmaceutical Company Limited
      1. 7.12.1. Company Overview
      2. 7.12.2. Product/Service Portfolio
      3. 7.12.3. Takeda Pharmaceutical Company Limited Sales, Revenue, and Gross Margin
      4. 7.12.4. Takeda Pharmaceutical Company Limited Revenue and Growth Rate
      5. 7.12.5. Takeda Pharmaceutical Company Limited Market Share
      6. 7.12.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
  8. Chapter 8 Blood Plasma Fractionation — Industry Analysis
    1. 8.1. Introduction and Taxonomy
    2. 8.2. Blood Plasma Fractionation Market – Key Trends
      1. 8.2.1. Market Drivers
      2. 8.2.2. Market Restraints
      3. 8.2.3. Market Opportunities
    3. 8.3. Value Chain Analysis
    4. 8.4. Key Mandates and Regulations
    5. 8.5. Technology Roadmap and Timeline
    6. 8.6. Blood Plasma Fractionation Market – Attractiveness Analysis
      1. 8.6.1. By Product
      2. 8.6.2. By Application
      3. 8.6.3. By End-User
      4. 8.6.4. By Region
  9. Chapter 9 Industrial Chain, Sourcing Strategy, and Downstream Buyers
    1. 9.1. Blood Plasma Fractionation Industrial Chain Analysis
    2. 9.2. Downstream Buyers
    3. 9.3. Distributors/Traders List
  10. Chapter 10 Marketing Strategy Analysis
    1. 10.1. Marketing Channel
    2. 10.2. Direct Marketing
    3. 10.3. Indirect Marketing
    4. 10.4. Marketing Channel Development Trends
    5. 10.5. Economic/Political Environmental Change
  11. Chapter 11 Report Conclusion & Key Insights
    1. 11.1. Key Insights from Primary Interviews & Surveys Respondents
    2. 11.2. Key Takeaways from Analysts, Consultants, and Industry Leaders
  12. Chapter 12 Research Approach & Methodology
    1. 12.1. Report Description
    2. 12.2. Research Scope
    3. 12.3. Research Methodology
      1. 12.3.1. Secondary Research
      2. 12.3.2. Primary Research
      3. 12.3.3. Statistical Models
        1. 12.3.3.1. Company Share Analysis Model
        2. 12.3.3.2. Revenue Based Modeling
      4. 12.3.4. Research Limitations

      List of Figures

      Fig.1	Product Picture of Blood Plasma Fractionation
      Fig.2	Global Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
      Fig.3	Global Blood Plasma Fractionation Market Absolute Revenue Opportunity, 2016 – 2026 (USD Billion)
      Fig.4	Global Blood Plasma Fractionation Market Incremental Revenue Opportunity, 2020 – 2026 (USD Billion)
      Fig.5	Global Blood Plasma Fractionation Market Share, by Product, 2019 & 2026 (USD Billion)
      Fig.6	Global Albumin  Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
      Fig.7	Global Immunoglobulin  Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
      Fig.8	Global Coagulation Factors  Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
      Fig.9	Global Protease Inhibitors  Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
      Fig.10	Global Others Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
      Fig.11	Global Blood Plasma Fractionation Market Share, by Application, 2019 & 2026 (USD Billion)
      Fig.12	Global Immunology & Neurology Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
      Fig.13	Global Hematology  Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
      Fig.14	Global Critical Care  Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
      Fig.15	Global Pulmonology Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
      Fig.16	Global Others Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
      Fig.17	Global Blood Plasma Fractionation Market Share, by End-User, 2019 & 2026 (USD Billion)
      Fig.18	Global Hospitals & Clinics Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
      Fig.19	Global Research Laboratories  Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
      Fig.20	Global Academic Institutes Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
      Fig.21	Global Blood Plasma Fractionation Market Share, by Region, 2019 & 2026 (USD Billion)
      Fig.22	North America Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
      Fig.23	U.S. Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
      Fig.24	Canada Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
      Fig.25	Europe Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
      Fig.26	Germany Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
      Fig.27	France Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
      Fig.28	U.K. Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
      Fig.29	Italy Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
      Fig.30	Spain Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
      Fig.31	Rest of Europe Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
      Fig.32	Asia Pacific Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
      Fig.33	China Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
      Fig.34	Japan Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
      Fig.35	India Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
      Fig.36	South  Korea Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
      Fig.37	South-East Asia Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
      Fig.38	Rest of Asia Pacific Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
      Fig.39	Latin America Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
      Fig.40	Brazil Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
      Fig.41	Mexico Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
      Fig.42	Rest of Latin America Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
      Fig.43	The Middle-East and Africa Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
      Fig.44	GCC Countries Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
      Fig.45	South Africa Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
      Fig.46	Rest of Middle-East Africa Blood Plasma Fractionation Market, 2016 – 2026 (USD Billion)
      Fig.47	Competitor Market Share – Revenue
      Fig.48	CSL Revenue and Growth Rate
      Fig.49	CSL Market Share
      Fig.50	Grifols Revenue and Growth Rate
      Fig.51	Grifols Market Share
      Fig.52	Shire Revenue and Growth Rate
      Fig.53	Shire Market Share
      Fig.54	Octapharma Revenue and Growth Rate
      Fig.55	Octapharma Market Share
      Fig.56	Kedrion Revenue and Growth Rate
      Fig.57	Kedrion Market Share
      Fig.58	BPL Revenue and Growth Rate
      Fig.59	BPL Market Share
      Fig.60	Baxter International Inc Revenue and Growth Rate
      Fig.61	Baxter International Inc Market Share
      Fig.62	Bio Product Laboratory Revenue and Growth Rate
      Fig.63	Bio Product Laboratory Market Share
      Fig.64	Biotest AG Revenue and Growth Rate
      Fig.65	Biotest AG Market Share
      Fig.66	LFB Revenue and Growth Rate
      Fig.67	LFB Market Share
      Fig.68	Sanquin Blood Supply Foundation Revenue and Growth Rate
      Fig.69	Sanquin Blood Supply Foundation Market Share
      Fig.70	Takeda Pharmaceutical Company Limited Revenue and Growth Rate
      Fig.71	Takeda Pharmaceutical Company Limited Market Share
      Fig.72	Market Dynamics
      Fig.73	Global Blood Plasma Fractionation – Value Chain Analysis
      Fig.74	Key Mandates and Regulations
      Fig.75	Technology Roadmap and Timeline
      Fig.76	Market Attractiveness Analysis – By Product
      Fig.77	Market Attractiveness Analysis – By Application
      Fig.78	Market Attractiveness Analysis – By End-User
      Fig.79	Market Attractiveness Analysis – By Region
      Fig.80	Blood Plasma Fractionation Industrial Chain Analysis
      Fig.81	Market Channels
      Fig.82	Marketing Channel Development Trend
      Fig.83	Growth in World Gross Product, 2008-2018
      

      List of Tables

      Table 1	Global Blood Plasma Fractionation Market, 2019 & 2026 (USD Billion)
      Table 2	Global Blood Plasma Fractionation Market, by Product, 2016 – 2026 (USD Billion)
      Table 3	Global Blood Plasma Fractionation Market, by Application, 2016 – 2026 (USD Billion)
      Table 4	Global Blood Plasma Fractionation Market, by End-User, 2016 – 2026 (USD Billion)
      Table 5	Global Blood Plasma Fractionation Market, by Region, 2016 – 2026 (USD Billion)
      Table 6	North America Blood Plasma Fractionation Market, by Country, 2016 – 2026 (USD Billion)
      Table 7	North America Blood Plasma Fractionation Market, by Product, 2016 – 2026 (USD Billion)
      Table 8	North America Blood Plasma Fractionation Market, by Application, 2016 – 2026 (USD Billion)
      Table 9	North America Blood Plasma Fractionation Market, by End-User, 2016 – 2026 (USD Billion)
      Table 10 Europe Blood Plasma Fractionation Market, by Country, 2016 – 2026 (USD Billion)
      Table 11 Europe Blood Plasma Fractionation Market, by Product, 2016 – 2026 (USD Billion)
      Table 12 Europe Blood Plasma Fractionation Market, by Application, 2016 – 2026 (USD Billion)
      Table 13 Europe Blood Plasma Fractionation Market, by End-User, 2016 – 2026 (USD Billion)
      Table 14 Asia Pacific Blood Plasma Fractionation Market, by Country, 2016 – 2026 (USD Billion)
      Table 15 Asia Pacific Blood Plasma Fractionation Market, by Product, 2016 – 2026 (USD Billion)
      Table 16 Asia Pacific Blood Plasma Fractionation Market, by Application, 2016 – 2026 (USD Billion)
      Table 17 Asia Pacific Blood Plasma Fractionation Market, by End-User, 2016 – 2026 (USD Billion)
      Table 18 Latin America Blood Plasma Fractionation Market, by Country, 2016 – 2026 (USD Billion)
      Table 19 Latin America Blood Plasma Fractionation Market, by Product, 2016 – 2026 (USD Billion)
      Table 20 Latin America Blood Plasma Fractionation Market, by Application, 2016 – 2026 (USD Billion)
      Table 21 Latin America Blood Plasma Fractionation Market, by End-User, 2016 – 2026 (USD Billion)
      Table 22 The Middle-East and Africa Blood Plasma Fractionation Market, by Country, 2016 – 2026 (USD Billion)
      Table 23 The Middle-East and Africa Blood Plasma Fractionation Market, by Product, 2016 – 2026 (USD Billion)
      Table 24 The Middle-East and Africa Blood Plasma Fractionation Market, by Application, 2016 – 2026 (USD Billion)
      Table 25 The Middle-East and Africa Blood Plasma Fractionation Market, by End-User, 2016 – 2026 (USD Billion)
      Table 26 Global Blood Plasma Fractionation Market - Company Revenue Analysis, 2016 – 2019 (USD Billion)
      Table 27 Global Blood Plasma Fractionation Market - Company Revenue Share Analysis, 2016 – 2019 (%)
      Table 28 Acquisitions and Mergers
      Table 29 Market Drivers – Impact Analysis
      Table 30 Market Restraints
      Table 31 Market Opportunities
      Table 32 Major Buyers of Blood Plasma Fractionation
      Table 33 Distributors/Traders of Blood Plasma Fractionation by Region
      

Covid-19

Blood Plasma Fractionation Market

The pandemic continues to cause unprecedented disruption across industries worldwide.Get detailed insights regarding the impact of COVID-19 on the market. Request Sample

Industry Major Market Players

  • CSL
  • Grifols
  • Shire
  • Octapharma
  • Kedrion
  • BPL
  • Baxter International Inc.
  • Bio Product Laboratory
  • Biotest AG
  • LFB
  • Sanquin Blood Supply Foundation
  • Takeda Pharmaceutical Company Limited
     

Frequently Asked Questions

Strict enforcement of laws by government authorities mandating Blood Plasma Fractionation Market.
According to Facts and Factors research report, the global Blood Plasma Fractionation Market accrued earnings worth approximately XX (USD Billion) in 2020 and is predicted to gain revenue of about XX(USD Billion) by 2028, is set to record a CAGR of nearly XX% over the period from 2021 to 2028.
North America will contribute lucratively towards the global market value over the estimated timeline. The regional market surge is subject to large-scale presence of giant participants in countries such as the U.S. Apart from this, favorable compensation policies along with high acceptance of new Blood Plasma Fractionation Market will drive regional market trends. With regional governments enforcing strict laws pertaining to drug abuse, the market for Blood Plasma Fractionation Market in North America is set to witness exponential growth over years to come. Legalization of cannabis in countries such as Canada and U.S. through passing of acts in parliament is likely to enlarge scope of Blood Plasma Fractionation Market in North America over coming decade.
why choose fnf
key questions answers

Related Reports

report img

Dental Periodontics Market

[212+ Pages Report] According to Facts Factors, the global dental periodontics market report encompasses the complete market breakdown structure. The global dental periodontics market is estimated to have witnessed a value of USD 15 Billion in 2020 and with growth at a CAGR of 10% during 2021-202...

Published Date : 23-Nov-2021 | | Category : | Pages : 212 | Format : Read more

Inquiry for Buying Request Sample
report img

DNA Forensics Market

[197+ Pages Report] Facts Factors published a report on the global DNA Forensics Market that encompasses a complete market synopsis. The DNA Forensics market is expected to grow at a CAGR value of 19% from an initial value of USD 30100 Million in 2020 to USD 6000 Million by 2026. Global DNA For...

Published Date : 22-Nov-2021 | | Category : | Pages : 197 | Format : Read more

Inquiry for Buying Request Sample